Richard D. Truesdell, Jr.

Davis Polk advised the underwriters in connection with an initial public offering of 7,500,000 shares of common stock of Deciphera Pharmaceuticals, Inc., at $17.00 per share, for total…

Davis Polk advised the joint book-running managers and representatives of the underwriters on the $172.5 million initial public offering by Zai Lab Limited of 9,583,333 American…

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A/Regulation S offering by ViaSat, Inc. of $700 million aggregate principal amount of its…

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $1.74 billion secondary offering of 97,750,000 shares of Class A…

 Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by Zoetis Inc. of $750 million aggregate principal amount of its 3.000% senior…

Davis Polk advised the joint lead arrangers and joint bookrunners in connection with a $6.5 billion 364-day senior unsecured bridge loan facility for United Technology Corporation to…

Davis Polk advised Tyson Foods, Inc. in connection with its SEC-registered offerings of $900 million aggregate principal amount of senior notes in two series, consisting of $400 million…

Davis Polk advised the sole book-running manager on an SEC-registered offering by Celgene Corporation of $500 million aggregate principal amount of 2.250% senior notes due 2021. …

Davis Polk advised the representative of the underwriters in connection with the $402.5 million public offering of 5,296,053 shares of common stock of Spark Therapeutics, Inc. The…

Davis Polk advised Delek Drilling LP, as the selling shareholder, and Tamar Petroleum Limited, as the issuer, on Tamar Petroleum’s international offering of 2,660,000 of its ordinary shares…